| Literature DB >> 29124076 |
David E Hartigan1,2, Itay Perets1, John P Walsh1,3, Edwin O Chaharbakhshi1,4, Leslie C Yuen1, Benjamin G Domb1,5.
Abstract
BACKGROUND: Femoral retroversion has been noted as a possible risk factor for poor clinical results after hip arthroscopic surgery.Entities:
Keywords: femoral retroversion; hip arthroscopic surgery; hip impingement; hip retroversion
Year: 2017 PMID: 29124076 PMCID: PMC5661671 DOI: 10.1177/2325967117732726
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Demographics of Retroverted and Control Groups
| Retroverted | Control |
| |
|---|---|---|---|
| Sex, n | .45 | ||
| Male | 23 | 19 | |
| Female | 36 | 40 | |
| Body mass index, kg/m2 | 25.3 ± 4.0 | 24.9 ± 3.9 | .43 |
| Age, y | 36.1 ± 12.6 | 36.3 ± 13.0 | .91 |
| Laterality, n | .27 | ||
| Right | 28 | 35 | |
| Left | 31 | 24 | |
| Follow-up time, mo | 37.6 ± 14.9 | 37.9 ± 14.1 | .58 |
| Conversion to THA, n | 3 | 2 | >.99 |
| Time to THA, mo | 26.3 ± 4.1 | 19.5 ± 18.9 |
aValues are shown as mean ± SD unless otherwise specified. THA, total hip arthroplasty.
Procedures Conducted in Retroverted and Control Groups
| Retroverted | Control |
| |
|---|---|---|---|
| Labral treatment |
| .4923 | |
| Repair | 39 | 35 | |
| Reconstruction | 2 | 1 | |
| Debridement | 17 | 23 | |
| Capsular treatment |
|
| |
| Repair | 31 | 19 | |
| No repair | 28 | 40 | |
| Acetabuloplasty | 50 | 45 | .3529 |
| Microfracture | 4 | 8 | .3617 |
| Femoroplasty | 52 | 45 | .1476 |
| Iliopsoas release | 19 | 24 | .1138 |
| Ligamentum teres treatment | 20 | 27 | .2591 |
| Notchplasty | 2 | 7 | .1626 |
Values are shown as No. unless otherwise specified. Bolded value indicates statistically significant difference between groups (P < .05).
Radiographic Findings in Retroverted and Control Groups
| Retroverted | Control |
| |
|---|---|---|---|
| LCEA, deg | |||
| Preoperative | 30.9 ± 4.9 | 30.3 ± 5.3 | .649 |
| Postoperative | 29.0 ± 4.7 | 28.3 ± 4.9 | .466 |
| | .0604 | .0504 | |
| ACEA, deg | |||
| Preoperative | 28.5 ± 10.4 | 30.8 ± 6.2 | .530 |
| Postoperative | 30.8 ± 6.6 | 30.5 ± 7.3 | .824 |
| | .560 | .847 | |
| Tönnis angle, deg | |||
| Preoperative | 3.6 ± 3.8 | 3.9 ± 4.1 | .945 |
| Postoperative | 3.6 ± 3.6 | 3.9 ± 3.9 | .675 |
| | .978003203 | .960175041 | |
| Alpha angle, deg | |||
| Preoperative | 60.5 ± 11.5 | 59.3 ± 13.3 | .465 |
| Postoperative | 44.7 ± 8.7 | 43.0 ± 6.8 | .529 |
| | <.001 | <.001 |
Values are shown as mean ± SD unless otherwise specified. ACEA, anterior center-edge angle; LCEA, lateral center-edge angle.
Figure 1.Preoperative (pre-op) and postoperative patient-reported outcome (PRO) scores for the retroverted and control groups. HOS-SSS, Hip Outcome Score–Sports-Specific Subscale; mHHS, modified Harris Hip Score; NAHS, Non-Arthritic Hip Score.
Figure 2.Visual analog scale (VAS) scores preoperatively (pre-op) and at >2-year follow-up in the retroverted and control groups.
Figure 3.Patient-reported outcome and visual analog scale (VAS) scores between the retroverted and control groups over time in months. HOS-SSS, Hip Outcome Score–Sports-Specific Subscale; mHHS, modified Harris Hip Score; NAHS, Non-Arthritic Hip Score.
Patient-Reported Outcome and VAS Scores Between Retroverted and Control Groups
| Preoperative | Postoperative | Change | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Retroverted | Control |
| Retroverted | Control |
| Retroverted | Control |
| |
| mHHS | 61.8 ± 14.6 | 63.4 ± 15.9 | .481 | 81.7 ± 14.8 | 80.7 ± 19.3 | .883 | 15.4 ± 21.2 | 14.1 ± 20.6 | .596 |
| HOS-SSS | 45.7 ± 25.5 | 44.8 ± 23.8 | .89 | 69.4 ± 28.0 | 65.3 ± 33.1 | .723 | 24.1 ± 31.6 | 20.7 ± 30.2 | .874 |
| NAHS | 62.0 ± 17.3 | 59.5 ± 18.9 | .569 | 82.4 ± 13.7 | 78.1 ± 21.8 | .51 | 20.6 ± 22.1 | 18.3 ± 19.4 | .489 |
| VAS | 5.7 ± 2.1 | 5.9 ± 2.3 | .889 | 2.7 ± 2.3 | 2.6 ± 2.5 | .658 | –3.0 ± 3.0 | –3.2 ± 3.1 | .993 |
Values are shown as mean ± SD unless otherwise specified. HOS-SSS, Hip Outcome Score–Sports-Specific Subscale; mHHS, modified Harris Hip Score; NAHS, Non-Arthritic Hip Score; VAS, visual analog scale.